HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).

AuthorsS H Lee, L K Thomas, F M Unger, R Christian, A C Sartorelli
JournalInternational journal of cancer (Int J Cancer) Vol. 27 Issue 5 Pg. 703-8 (May 15 1981) ISSN: 0020-7136 [Print] United States
PMID6974703 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adenosine Deaminase Inhibitors
  • Antineoplastic Agents
  • DNA, Neoplasm
  • Coformycin
  • Pentostatin
  • arazide
  • Vidarabine
Topics
  • Adenosine Deaminase Inhibitors
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Cells, Cultured
  • Coformycin (analogs & derivatives, therapeutic use)
  • DNA, Neoplasm (biosynthesis)
  • Drug Therapy, Combination
  • Leukemia P388 (drug therapy)
  • Leukemia, Experimental (drug therapy)
  • Mice
  • Pentostatin
  • Vidarabine (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: